Combined [qlco]
Bezafibrate [orch, phsu]
treatment [ftcn]
Mixed hyperlipidaemia [dsyn]
Safety [hcpp]
Efficacy [qlco]
Combined therapy [topp]
Bezafibrate [orch, phsu]
Simvastatin [orch, phsu]
Evaluated [ftcn]
Patients [podg]
Diet [food]
Resistant [ftcn]
Mixed hyperlipidaemia [dsyn]
placebo [topp]
Phase [tmco]
Patients [podg]
randomized [resa]
Receive [qlco]
Bezafibrate 400 MG [clnd]
Slow [qlco]
Release [hlca]
Mane [bpoc]
Simvastatin 20 MG [clnd]
nocte [tmco]
months [tmco]
Combination Therapy [topp]
Total Cholesterol [lbpr]
Triglycerides [bacs, lipd]
High Density Lipoprotein Cholesterol [bacs, lipd]
Measured [qlco]
Monthly [tmco]
intervals [tmco]
Apolipoproteins [aapp, bacs]
Lipoprotein (a) [aapp, bacs]
Lp(a) [aapp, bacs]
Fibrinogen [aapp, bacs, phsu]
Measured [qlco]
treatment [ftcn]
Simvastatin [orch, phsu]
effective [qlco]
Bezafibrate [orch, phsu]
Slow [qlco]
Release [hlca]
Reducing [qlco]
Total Cholesterol [lbpr]
mmol/L [qnco]
P NOS [aapp, imft]
lowering [spco]
Cholesterol, LDL [bacs, strd]
1-7 [gngm]
mmol/L [qnco]
P NOS [aapp, imft]
Bezafibrate [orch, phsu]
Slow [qlco]
Release [hlca]
effective [qlco]
Reducing [qlco]
Triglycerides [bacs, lipd]
P NOS [aapp, imft]
Fibrinogen [aapp, bacs, phsu]
P NOS [aapp, imft]
Compared [acty]
Simvastatin [orch, phsu]
Combined therapy [topp]
Drug [phsu]
Induced [ftcn]
reductions [npop]
Triglycerides [bacs, lipd]
P NOS [aapp, imft]
Apo-B [aapp, bacs]
mg dl [qnco]
P NOS [aapp, imft]
Apo A-1 [aapp, bacs]
mg dl [qnco]
P NOS [aapp, imft]
Symptomatic [ftcn]
Biochemical [ftcn]
adverse events [fndg]
Frequently [tmco]
Combined therapy [topp]
Drug [phsu]
Combination [qlco]
Bezafibrate [orch, phsu]
Simvastatin [orch, phsu]
effective [qlco]
controlling [ftcn]
Mixed hyperlipidaemia [dsyn]
Drug [phsu]
Alone [qnco]
adverse events [fndg]
